MR-Guided Single-Fraction Stereotactic Ablative Body Radiation Therapy for Extracranial Metastases: The Miami Cancer Institute Experience

Authors

Michael Chuong, Baptist Health Medical Group; Miami Cancer InstituteFollow
Robert Herrera, Miami Cancer InstituteFollow
Kathryn Mittauer, Miami Cancer InstituteFollow
Carolina Rojas, Miami Cancer InstituteFollow
Muni Rubens, Baptist Health South FloridaFollow
Adeel Kaiser, Miami Cancer InstituteFollow
Noah Kalman, Baptist Health Medical Group; Miami Cancer InstituteFollow
Nema Bassiri
Antonio Ucar, Baptist Health Medical Group; Miami Cancer InsituteFollow
Federico Albrecht, Miami Cancer InstituteFollow
Fernando deZarraga Jr, Miami Cancer InstituteFollow
Paul Kaywin, Miami Cancer InstituteFollow
Santiago Aparo, Miami Cancer InstituteFollow
Sarah Joseph, Miami Cancer InstituteFollow
Alonso Gutierrez, Miami Cancer InstituteFollow
Rupesh Kotecha, Miami Cancer InstituteFollow

Files

Publication Date

4-23-2025

Content Type

Poster

Recommended Citation

Chuong, Michael; Herrera, Robert; Mittauer, Kathryn; Rojas, Carolina; Rubens, Muni; Kaiser, Adeel; Kalman, Noah; Bassiri, Nema; Ucar, Antonio; Albrecht, Federico; deZarraga, Fernando Jr; Kaywin, Paul; Aparo, Santiago; Joseph, Sarah; Gutierrez, Alonso; and Kotecha, Rupesh, "MR-Guided Single-Fraction Stereotactic Ablative Body Radiation Therapy for Extracranial Metastases: The Miami Cancer Institute Experience" (2025). 2025 Baptist Health Academic Conference: Leading Tomorrow's Healthcare Through Innovation. 16.
https://scholarlycommons.baptisthealth.net/bhsf-academic-week-2025/16